相关实验视频
Updated: Jan 13, 2026

14:49
Associated Chromosome Trap for Identifying Long-range DNA Interactions
Published on: April 23, 2011
14.9K
作为结肠癌的预后标记物,与伊塔康酸相关的基因签名:从转录和空间分析的见解
Tingting Zhang1, Jianchao Meng1, Qingyun Wang2
1Department of Clinical Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, China, hbmu.edu.cn.
Human mutation
|January 12, 2026
概括
这项研究确定了10个关键基因,用于预测结肠癌的预后,使用多omics数据. 一个新的模型准确地预测了患者的结果,并建议针对性疗法,以改善结肠癌治疗.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 结肠癌的预后和治疗需要更好的预测工具.
- 了解瘤微环境中的基因表达对于个性化医学至关重要.
研究的目的:
- 在结肠癌中全面分析伊塔科纳酸和霍尔马克通路相关基因.
- 开发和验证一种新的结肠癌预后预测模型.
- 探索预后基因的细胞特异表达和空间分布.
主要方法:
- 使用了癌症基因组图谱 (TCGA) 和基因表达总汇 (GEO) 数据库.
- 应用散装,单细胞 (scRNAseq) 和空间转录组学.
- 使用10个选定的基因构建并验证了一个预后预测模型 (Enet [alpha = 0.2]).
主要成果:
- 已经确定了10个与预后相关的基因 (TIMP1,FJX1,CD36,CXCL1,ETS2,CDKN2A,INHBB,PLEC,TUBB2,P4HA1).
- 埃内特模型表现出强大的预测价值 (平均C指数>0.7),并且表现优于现有模型.
- 高风险患者表现出较高的瘤突变负担,免疫检查点基因表达,以及对特定药物 (如化) 的潜在敏感性.
结论:
- 开发的预后模型为准确的结肠癌预后提供了一个强大的工具.
- 已识别的基因和途径为分层治疗策略提供了新的目标.
- 这些发现支持免疫疗法和针对性药物选择在高风险结肠癌患者的潜力.
相关概念视频
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K

